Company overview
Titan Enterprises is a UK-based manufacturer of high-performance small-bore liquid flowmeters for pharmaceutical, medical, laboratory research, and bio-engineering applications. Their products feature chemical resistance, clean bore design, low flow capabilities, and long-life durability to support precise flow measurement in demanding environments. With production exceeding 70,000 units annually and distribution across more than 40 countries, they provide reliable OEM solutions for global pharma and life sciences sectors.
Flowmeters by Titan Enterprises Ltd is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include pharma flow meters, liquid flowmeters, oem flow sensors, pharmaceutical flow measurement, clean bore flowmeters.
Structured facts
- Website
- https://flowmeters.co.uk
- Markets served
- United States & Americas
- Keywords
- pharma flow meters, liquid flowmeters, oem flow sensors, pharmaceutical flow measurement, clean bore flowmeters
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What flowmeter capabilities does Titan Enterprises offer for pharmaceutical applications?
- Titan provides small-bore liquid flowmeters with chemical resistance, clean bore, low flow detection, and long-life features suitable for pharma, medical, laboratory, and bio-engineering uses.
- What industries and geographies does Titan Enterprises serve?
- They serve pharmaceuticals, medical, laboratories, bio-engineering, and more across over 40 countries with strong presence in Europe, America, Australia, and East Asia via global distributors.
- Are Titan Enterprises flowmeters suitable for OEM integration in pharma equipment?
- Yes, they design and manufacture flowmeters for OEM and end-user customers, producing over 70,000 units yearly for precise applications in pharma and related sectors.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.